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Objectives This study was undertaken to determine the effects of creating a systemic-to-pulmonary venous atrial-level com-
munication (fenestration) at the time of the Fontan procedure on late outcomes.
Background Fenestrations are frequently performed during Fontan procedures, but late consequences are not well described.
Methods Patient characteristics were compared between those with and without surgical fenestration among 536 sub-
jects (mean age 11.9 years) enrolled in the Pediatric Heart Network Fontan Cross-Sectional Study. The status of
the fenestration and the association of a currently patent fenestration with health status and measures of ven-
tricular performance were investigated.
Results Fenestration was performed in 361 patients (67%), and frequency differed by year and center (p  0.001 for
each). After adjustment for center, age at Fontan, year of Fontan, and prior superior cavopulmonary surgery, the
fenestrated group had shorter length of Fontan hospital stay. At the time of cross-sectional testing 8  3 years
after Fontan, the fenestration remained open in 19% of subjects. Among those with confirmed fenestration clo-
sure, 59% were by catheter intervention and 1% by surgical intervention, and 40% had apparent spontaneous
closure. Compared with those without evidence of a fenestration, subjects with a current fenestration were tak-
ing more medications (p  0.02) and had lower resting oxygen saturation (median 89% vs. 95%, p  0.001).
Functional health status, exercise performance, echocardiographic variables, prevalence of post-Fontan stroke or
thrombosis, and growth did not differ by current fenestration status.
Conclusions Surgical fenestration is associated with well-demonstrated early post-operative benefits. This cross-sectional
study found few associations between a persistent fenestration and deleterious later outcomes. (J Am Coll
Cardiol 2011;57:2437–43) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.031The Fontan procedure has provided excellent surgical pal-
liation for many patients with functional single-ventricle
physiology and has evolved over time (1). Creation of a
systemic-to-pulmonary venous atrial-level communication
(or fenestration) at the time of Fontan completion may
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2010, accepted January 2, 2011.benefit patients by limiting Fontan pathway pressure and
creating a right to left atrial shunt, which may augment
cardiac output and limit central venous pressure in the
immediate post-operative period, at the expense of sys-
temic desaturation with potential long-term sequelae.
Retrospective, single-center reports suggest that in high-
risk patients, those with a fenestrated Fontan have
shorter duration of pleural effusion and shorter length of
hospital stay (2,3). Subsequently, similar short-term peri-
operative benefits of fenestration creation have been
shown in a single-center randomized study involving
standard-risk patients (4). Although this procedure is
now commonly performed, long-term benefits, if any, are
not documented. Additionally, concerns remain about
the need for later intervention to close the fenestration, as
well as risks of persistent cyanosis and paradoxical em-
bolization in patients with patent fenestrations.
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Fontan Patients With Persistent Fenestration June 14, 2011:2437–43The Pediatric Heart Network
(PHN) Fontan Cross-Sectional
database (5) provides a very well-
characterized cohort of surviving
subjects from 7 North American
centers in which to examine
whether creation of a fenestra-
tion at the time of Fontan is
associated with long-term health
status, medical complications, or
laboratory measures of cardiac
function. Additionally, compari-
sons can be made between sub-
jects with a currently patent fen-
estration and those without.
Methods
Data for analyses described here were obtained from 536
subjects enrolled from 7 clinical centers participating in the
National Institutes of Health/National Heart, Lung, and
Blood Institute–funded PHN Fontan Cross-Sectional
Study. Subjects in this study were survivors of multistage
surgical palliation for functional single ventricle culminating
in a Fontan procedure who were 6 to 18 years of age at the
time of sampling. Medical records were screened for 1,078
patients, of whom 831 (77%) were deemed potentially
eligible for participation. After being contacted, 637 pa-
tients (60%) were fully eligible, and consent was obtained
from 546 (86%). Subjects with a hepatic vein exclusion
procedure (n  10) were excluded from this analysis. The
median time between Fontan surgery and study enrollment
was 8.1 years. Complete details of the study design have
been previously published (6).
Measurements. Demographic data and descriptors of
medical history before, during, and after the Fontan proce-
dure were obtained by medical record review. Standardized
assessment of functional health status was obtained using
the Parent Report Child Health Questionnaire (CHQ
P50). Physical performance was assessed using bicycle
ergometry (7). Ventricular size and function, atrioventricu-
lar valve and semilunar valve regurgitation, and fenestration
status were obtained using centrally interpreted echocardio-
graphic measurements. Resting B-type natriuretic peptide
(BNP) concentration was obtained and analyzed at a core
laboratory.
Statistical analysis. Exploratory analyses incorporating
graphical and tabular displays assessed evidence in favor of
trends and associations. Sample means, medians, and pro-
portions accompanied by 95% confidence intervals provided
descriptive summaries. Crude comparisons of subjects with
and without surgical fenestration used Student t and chi-
quare test statistics. Covariate-adjusted comparisons were
btained by multiple linear and logistic regression analyses.
moothed estimates of the proportion of subjects who
Abbreviations
and Acronyms
AV  atrioventricular valve
BNP  B-type natriuretic
peptide
CHQ P50  Parent Report
Child Health Questionnaire
PHN  Pediatric Heart
Network
PLE  protein-losing
enteropathy
stage II  cavopulmonary
anastomosisnderwent surgical fenestration were performed as a func- pion of time and were obtained using generalized additive
ixed models with study center entered as a random effect.
raphical analyses of the time to hospital discharge after
ontan surgery for this cohort of Fontan survivors were
erformed using the Kaplan-Meier method, with signifi-
ance testing via log-rank tests; covariate-adjusted models
or time to discharge were constructed using Cox propor-
ional hazards regression. Analyses were performed using
AS software version 9.2 (SAS Institute, Cary, North
arolina) and the R system version 2.8.1 (R Foundation for
tatistical Computing, Vienna, Austria).
djustment for covariates. We learned in previous analy-
es that many of the results of tests performed at the time of
ross-sectional evaluation differed among age groups. Exer-
ise performance decreased with age (7). Echocardiographi-
ally measured mass-to-volume ratio, dP/dt (rate of rise of
eft ventricular pressure), and Tei index also varied by age
5). Therefore, for outcomes measured at the time of
ross-sectional testing (e.g., CHQ P50, echocardiography,
nd exercise testing), age-adjusted comparisons are re-
orted. Because the cohort of patients with a current
enestration were younger and followed for less time since
ontan completion, medical history variables collected since
ontan hospitalization are also reported using age-adjusted
omparisons. Medication use among Fontan patients and
erformance of certain catheter interventions varied consid-
rably across the 7 participating centers in the PHN (8,9).
herefore, where center or era differences might exist, we
djusted for subject age at Fontan cross-sectional enroll-
ent, year that Fontan surgery was performed, and study
enter. Based on the previously observed association be-
ween the performance of cavopulmonary anastomosis
stage II) procedures and fenestration performance, the
resence or absence of a prior stage II surgery was also
ncluded as a control factor in the post-Fontan medical
istory outcomes.
The Fontan Cross-Sectional Study protocol was ap-
roved by the PHN Protocol Review Committee and an
ndependent Data and Safety Monitoring Board, as well as
nstitutional Review Boards at each of the 7 clinical centers
nd the Data Coordinating Center. All centers followed the
ame protocol and study procedures.
esults
mong this enrolled cohort of Fontan survivors, there was
rapid increase in the performance of a surgical fenestration
etween 1987 and 1992 (Fig. 1). After 1992, the proportion
f Fontan procedures that included surgical fenestration
emained approximately 80%. Although the use of fenes-
ration increased over this time period at all centers, the
ercentage of subjects receiving a fenestration varied widely
mong centers (13% to 91%, p  0.001).
edical history before the Fontan procedure. Subject
nd medical history characteristics before and at the Fontan
rocedure are shown in Table 1. Age at cross-sectional
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June 14, 2011:2437–43 Fontan Patients With Persistent Fenestrationstudy enrollment was approximately 2 years older among the
subjects with no surgical fenestration (13.2  3.6 years vs.
11.2  3.2 years, p  0.001). Subjects who underwent
enestration were more likely to have had prior stage II
rocedures, (84% vs. 54%, p  0.005), have significant
re-existing atrioventricular valve (AV) regurgitation (40%
s. 24%, p  0.001), and have had a history of thrombosis
efore the Fontan procedure (6% vs. 2%, p  0.04) than
hose who did not undergo fenestration. At the pre-Fontan
atheterization procedure, subjects who went on to have a
enestration had higher systemic arterial oxygen saturations
85 5% vs. 83 5%, p 0.001) and lower ventricular end
iastolic pressures (7.6 mm Hg vs. 8.3 mm Hg, p  0.02)
ompared with those who did not undergo fenestration.
hen adjusted for center, age at enrollment, and year of
ontan procedure, there was no difference in numbers of
urgical procedures and catheter interventions before Fon-
an completion between subjects who did and did not
ndergo surgical fenestration.
Consistent with the association with age and era, surgical
enestration was related to the type of Fontan procedure
erformed; fenestration was more prevalent among subjects
ith total cavopulmonary connections and less prevalent
mong subjects on whom an atriopulmonary connection was
erformed.
tatus after Fontan procedure. Subjects with surgical
enestration had median length of stay approximately 2.5
ays shorter than subjects without fenestration (p  0.001)
Fig. 2). This association remained significant after adjust-
ng for study center, age at enrollment, year of Fontan, and
erformance of a stage II procedure (p  0.05).
Medical history during and after the Fontan hospitaliza-
ion is shown in Table 2. After adjusting for age, year at
Figure 1 Smoothed Proportion of Subjects
With Surgical Fenestration by Year
Rug plots at top and bottom record the dates of fenestrated and nonfenes-
trated procedures, respectively. Estimates were obtained using generalized
additive mixed models. A 95% confidence interval is displayed as a shaded
region.ontan, and performance of a stage II procedure, we foundssociations between surgical fenestration and increased
umber of discharge medications and increased number of
ost-Fontan catheter interventions (excluding procedures
elated to the fenestration itself). The 2 most common
atheter interventions performed in the fenestrated group
ere coiling of systemic venous collaterals and coiling of
ortopulmonary collaterals.
Fenestration was not associated with post-Fontan stroke,
entricular dysfunction, thrombosis, protein-losing enterop-
thy (PLE), or arrhythmia, even when the analyses were
Patient Characteristicsby Surgical Fenestration StatusTable 1 Pa ient Characteri ticsby Surgical Fenestration Status
Fenestration
(n  361)
No Fenestration
(n  175) p Value
Demographics
Age at study enrollment, yrs 11.2 3.2 13.2 3.6 0.001
Age at Fontan, yrs 3.5 2.3 3.3 1.8 0.4
Male 60 58 0.6
Medical history before Fontan
procedure
Anatomy 0.3
Double inlet left ventricle 13 18
Mitral atresia 6 5
Tricuspid atresia 21 26
Unbalanced atrioventricular
canal
4 5
Heterotaxy 8 7
Hypoplastic left heart syndrome 23 15 0.06
Other 26 24
Stage II performed 84 54 0.005*
Prior surgical procedures 3.3 2.0 2.5 1.7 0.3*
Prior non-stage II surgeries 2.4 1.9 1.9 1.5 0.3*
Prior catheter interventions 0.9 1.2 0.4 0.7 0.2*
Severity of AV valve regurgitation 0.001
None/trivial 60 76
Mild 33 23
Moderate/severe 7 1
EDP, mm Hg 7.6 3.4 8.3 3.0 0.02
Mean PA pressure, mm Hg 11.2 3.1 11.8 3.9 0.1
Oxygen saturation, % 84.6 4.9 82.8 5.3 0.001
Decreased ventricular function 18 17 0.9
Arrhythmia 20 24 0.3
Thrombosis 6 2 0.04
Medical history: Fontan procedure
Weight for age at Fontan,
percentile
26 28 28 27 0.5
Height for age at Fontan,
percentile
32 29 32 28 0.8
Type of Fontan 0.001
AP connection 6 30
TCPC intracardiac tunnel 65 45
TCPC extracardiac tunnel 14 12
TCPC extracardiac conduit 15 8
Other 1 5
Data are shown as mean  SD or %. *Adjusted for center, age at enrollment, and year of Fontan
rocedure.
AP  atriopulmonary; AV  atrioventricular; EDP  end-diastolic pressure; LV  left ventricle;
PA  pulmonary artery; RV  right ventricle; TCPC  total cavopulmonary connection.
2440 Atz et al. JACC Vol. 57, No. 24, 2011
Fontan Patients With Persistent Fenestration June 14, 2011:2437–43adjusted for age at enrollment, age at Fontan, center, and
performance of a stage II procedure.
Fate of the surgical fenestration. An echocardiographic
core laboratory determined “current” fenestration status at
study enrollment (a median 8.1 years after Fontan surgery)
in 527 of the 536 subjects (98%). Of the 361 subjects who
had surgical fenestration at Fontan, 356 had an available
echocardiogram (99%). At the time of cross-sectional test-
ing, the fenestration was open in 69 subjects (19%) and
Figure 2 Proportion of Subjects Achieving Hospital Discharge A
as a Function of Time Since the Start of the Fontan H
Proportion estimates were obtained using the Kaplan-Meier method in this cohort
Status After Fontan SurgeryTable 2 Status After Fontan Surgery
Characteristics
Fe
(
Length of hospital stay, days 1
Median
Post-operative complications, n
Median
Pericardial effusion
Pleural effusion
Discharge medications, n
Median
Antithrombotic
ACEI
Diuretics
Post-Fontan
Catheter interventions (excluding fenestration-related procedures), n
No. of surgeries
Stroke
Thrombosis
PLE
ArrhythmiaValues are mean  SD or %. *Adjusted for center, year of Fontan procedure, age at enrollment, and per
ACEI  angiotensin-converting enzyme inhibition; PLE  protein-losing enteropathy.closed in 227 (63%). It was not possible to clearly delineate
the fenestration status in 60 (17%) subjects.
In the 227 subjects who had a closed fenestration at study
enrollment, 91 (40%) are assumed to have had spontaneous
closure because no surgical procedures or catheter interven-
tions were performed after the Fontan procedure. Of those
subjects with an intervention, 133 (59%) of these underwent
closure by catheter intervention, and 3 (1%) underwent
closure during a surgical procedure. For subjects who
the Fontan Procedure
alization
tan survivors enrolled in this cross-sectional study.
ation
61)
No Fenestration
(n  175) p Value Adjusted p Value*
20.1 21.9 26.0 0.001 0.05
13.5
1.9 2.8 2.6 0.001 0.3
2
21 0.001 0.3
35 0.001 0.3
1 3 2 0.003 0.02
3
50 0.001 0.02
24 0.001 0.001
91 0.02 0.3
1.0 0.3 0.9 0.001 0.03
0.8 0.5 1.1 0.2 0.2
1 0.5 0.3
7 0.9 0.8
6 0.1 0.2
24 0.2 0.5fter
ospit
of Fonnestr
n  3
6.1
11.0
1.4
1
7
21
4
4
77
67
96
0.6
0.3
2
7
3
19formance of stage II procedure.
c
l
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June 14, 2011:2437–43 Fontan Patients With Persistent Fenestrationunderwent fenestration closure, the mean interval between
Fontan surgery and interventional closure was 8.5  3.5
years (range 1 day to 11 years). Considering only the
catheter-related fenestration closures, 116 were closed by a
septal occluder device, 3 by a coil, and 14 by closure of a
purse string placed around the fenestration at the time of
Fontan surgery.
Comparisons of subjects according to current fenestration
status. Comparisons of the 69 subjects who had an open
fenestration at study enrollment with the 458 subjects
without any atrial-level communication assessed by study
echocardiogram are shown in Table 3. The group with a
urrent fenestration was younger and had been followed for
ess time since Fontan (mean 7.1 years vs. 8.7 years, p 
0.001). Those with a current fenestration were more likely
to have had a prior stage II procedure and to have an
intra-cardiac lateral tunnel-type Fontan. Patients with a
current fenestration had lower resting oxygen saturation
than those without a current fenestration (89% vs. 95%, p
0.001). The 2 groups did not differ with respect to func-
tional health assessed by CHQ P50 summary scores. Height
and weight percentile calculated at the time of cross-
sectional testing did not differ by fenestration status. BNP
levels, angiographic and echocardiographic measures of
ventricular performance, and exercise variables did not differ
by current fenestration status, nor did they differ in respect
to post-Fontan complications, including number of addi-
tional interventional procedures, stroke, thrombosis, or
PLE.
Discussion
We report a large multicenter cohort of single-ventricle
patients palliated with a Fontan procedure and demonstrate
a dramatic change in surgical practice over time in the use of
a surgical fenestration. Fenestration was first introduced in
1990 in an effort to improve the perioperative course for
high-risk patients (2); more than 80% of subjects in our
cohort had an atrial fenestration at the time of the Fontan
operation after 1992. The population evaluated in this
cross-sectional study included patients in the pre-
fenestration era. Thus, the majority of subjects who did not
have a fenestration were from the early time period. They
were also somewhat older at the time of evaluation, less
likely to have had a stage II operation performed, and more
likely to have had an atriopulmonary connection, which was
the methodology of the original Fontan operation (9). In
the current study, we attempted to control for era effect by
adjusting for patient age and year of Fontan and to control
for practice variation by adjusting for study center. After
adjusting for these factors, surgical fenestration was associ-
ated with decreased length of Fontan hospital stay. This
cross-sectional study found few associations between a
persistent fenestration and deleterious later outcomes.Pre-operative risk factors do not consistently identify
patients who may have poorer outcomes after the Fontan
Subject Profiles by Current Fenestration StatusTable 3 Subject Profiles by Current Fenestration Status
Fenestration
(n  69)
No Fenestration
Detected
(n  458) p Value
Age at enrollment, yrs 10.7 3.3 12.0 3.4 0.002
Age at Fontan, yrs 3.7 2.3 3.4 2.1 0.3
Years since Fontan 7.1 3.2 8.7 3.5 0.001
Male 61 59 0.9
Stage II performed 93 80 0.005*
Anatomy 0.3
Double inlet left ventricle 12 15
Mitral atresia 7 5
Tricuspid atresia 13 24
Unbalanced atrioventricular
canal
3 4
Heterotaxy 9 7
Hypoplastic left heart
syndrome
26 19
Other 30 25
Type of Fontan 0.001
AP connection 0 16
TCPC intracardiac tunnel 80 56
TCPC extracardiac tunnel
lateral
9 14
TCPC extracardiac conduit 10 13
Other 1 2
Post-Fontan medical history
Weight for age at study,
percentile
29 28 35 31 0.2
Height for age at study,
percentile
36 30 42 33 0.2
Cardiac surgical procedures 0.3 0.6 0.4 1.0 0.8*
Catheter interventions 0.5 1.2 0.5 1.0 0.3*
Stroke 0 2 1.0*
Thrombosis 4 8 0.3*
PLE 3 4 1.0*
Arrhythmia 21 20 0.5*
Functional health assessed by
CHQ P50
Physical summary score 46 10 45 12 0.4*
Psychosocial summary
score
46 11 48 11 0.8*
Echocardiography
Echo EF, % 58 10 59 10 0.6*
Mass:volume ratio z score 1.2 0.5 1.2 0.4 0.5*
dP/dt, mm Hg/s 1,575 1,026 1,374 908 0.3*
Exercise testing
Resting O2 saturation (%) 89 5 95 4 0.001*
Peak VO2 (ml/kg/min) 25 6 27 6 0.2*
% Predicted peak VO2 63 14 67 15 0.1*
VO2 at VAT (ml/kg/min) 16 4 18 6 0.1*
% Predicted VO2 at VAT 67 14 77 22 0.1*
BNP (pg/ml) 34 72 25 44 1.0*
Data are shown as mean  SD or %. *Age-adjusted comparisons.
AP  atriopulmonary; BNP  B-type natriuretic peptide; CHQ P50  Parent Report Child Health
Questionnaire; EDV end-diastolic volume; EF ejection fraction; ESV end-systolic volume; LV left
ventricle; PLE  protein-losing enteropathy; RV  right ventricle; TCPC  total cavopulmonary
connection; VAT  ventilatory anaerobic threshold; VO2 maximal oxygen consumption.procedure, which has led some to suggest that some patients
2442 Atz et al. JACC Vol. 57, No. 24, 2011
Fontan Patients With Persistent Fenestration June 14, 2011:2437–43undergoing the Fontan do not require routine fenestration
(10,11). This large multicenter study supports the numerous
single-center reports indicating that an atrial fenestration
carried out at the time of the Fontan operation shortens
hospital stay (3,4,12). Not appreciated in prior studies, we
found an increased use of cardiac medications at discharge
in the fenestration group. After adjusting for subject age and
center, increased use of angiotensin-converting enzyme
inhibitors and antithrombotics in the fenestration group was
still observed.
Although considerable data regarding the early post-
operative effects of a fenestration at Fontan have been
previously reported, the long-term sequelae of a fenestration
on clinical outcomes are less well studied. We found that
subjects with a history of surgical fenestration at the time of
the Fontan operation had significantly greater numbers of
catheter interventions, even after excluding procedures car-
ried out for modification of the fenestration itself. One
might attribute this finding to the modern era when
interventions are more common. However, after correcting
for patent age, year of Fontan procedure, and center, we
continued to identify a greater number of post-Fontan
catheter interventions in the group who underwent surgical
fenestration.
Closure of a surgical fenestration has been advocated
because of complications associated with persistent cyanosis
and increased risk of systemic thromboembolism. As ex-
pected, we found that resting arterial oxygen saturation was
significantly lower among the 69 subjects who were docu-
mented to have a persistent fenestration at a median of 8
years after the Fontan procedure. However, an increased
incidence of either stroke or thrombosis was not found
among the patients with a persistent atrial communication.
This is consistent with smaller single-center reports that did
not find a difference in number of strokes (13) or occurrence
of thrombosis (12) in Fontan subjects with patent fenestra-
tions. Additionally, we found no differences in the number
of surgical or catheter interventions, incidence of PLE, or
incidence of arrhythmia between those with a current
fenestration and those without. Echocardiographic mea-
surements of ventricular function and mass-to-volume ratio
as well as exercise performance, BNP levels, and growth
parameters were similar in the 2 groups. Our findings are
consistent with previous reports demonstrating that fenes-
tration closure does not positively or negatively affect exer-
cise capacity (14). Functional health status as assessed by the
CHQ P50 also did not differ by current fenestration status.
Overall, despite lower resting oxygen saturation, we did not
identify any deleterious effects of a persistent fenestration in
our cohort.
The long-term fate of the surgical fenestration has not
been well described. In our cohort, 40% of subjects with a
surgical fenestration had apparent spontaneous closure.
Although the timing of such spontaneous closure is un-
known, this finding is consistent with prior small reports
that have documented spontaneous closure of fenestrationsin 29% of subjects within 3 months (15). Multiple centers
have reported methods for closing fenestration. Indications
for the procedure have also been proposed, and risk factors
associated with closure have been described (16,17). Closure
of a fenestration improves oxygenation and may reduce the
use of anti-congestive medication, but may result in in-
creased use of antiarrhythmic agents after closure (17).
Some have suggested that indications for routine fenestra-
tion closure should be reconsidered because of potential
long-term benefits of increased cardiac output and de-
creased tachyarrhythmias in patients with patent fenestra-
tions late after Fontan procedures (18).
Study limitations. The study cohort was limited to surviv-
ing subjects who agreed to participate in this study. The
fates of patients who were not enrolled are necessarily
unknown. Furthermore, the effects of fenestration and of
interventional closure on early or late mortality, if any, could
not be assessed in a cross-sectional study. We utilized a
central echocardiography core laboratory to determine cur-
rent fenestration status, but images were not available in 19
subjects (3%) and were inadequate to determine the status of
the fenestration in 60 subjects (17%). This may have limited
the power to detect differences between those with and
without a current fenestration.
Conclusions
The percentage of Fontan procedures that included surgi-
cally created atrial fenestrations increased rapidly over time
in subjects enrolled in this multicenter study. Subjects who
had surgical fenestration creation at Fontan had a shorter
length of stay, but received more medications at hospital
discharge. Most fenestrations were later closed in the
catheterization laboratory; however, a significant percentage
demonstrated spontaneous closure. Subjects with persistent
fenestrations at the time of the cross-sectional study had
significantly lower resting oxygen saturation. A persistent
fenestration, however, was not associated with exercise perfor-
mance, echocardiographic function, or functional health status.
Although patients with a current fenestration are theoretically
at ongoing risk for thromboembolic events, there was not an
increased incidence of these potentially serious complications
during the 8-year follow-up period. Further longitudinal
follow-up of this cohort is necessary to determine long-term
consequences of a persistent fenestration.
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